Summary & Overview
HCPCS C1600: Intravascular Lesion Preparation Catheter, Bladed
HCPCS Level II code C1600 designates a bladed, sheathed, insertable catheter used for transluminal intravascular lesion preparation. This device-category code is relevant to endovascular procedures aimed at preparing vascular lesions before definitive therapies such as angioplasty or stenting. Nationally, device-specific HCPCS codes like C1600 matter for accurate billing, device tracking, and payer coverage determinations across hospital outpatient departments, ambulatory surgery centers, and catheterization labs.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of code definition and clinical context, a summary of typical sites of service, and what to expect from payer coverage practices. The publication outlines common modifiers associated with device and procedure reporting, notes when data elements are not provided, and points to where clinicians and billing staff can look for policy updates. It also covers billing considerations relevant to endovascular device use and highlights the national importance of consistent coding for reimbursement and utilization monitoring.
Data not available in the input for associated taxonomies, specific ICD-10 diagnoses, related codes, and service line details.
Billing Code Overview
HCPCS Level II code C1600 describes a catheter, transluminal intravascular lesion preparation device, bladed, sheathed (insertable). This device is used intravascularly to prepare vascular lesions prior to definitive therapy, typically to modify or remove obstructive tissue within blood vessels.
Service Type: Intravascular lesion preparation device; endovascular peripheral intervention tool
Typical Site of Service: Hospital outpatient department, ambulatory surgery center, or catheterization lab
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with symptomatic peripheral arterial disease (PAD) of the lower extremity presenting with lifestyle-limiting claudication or critical limb ischemia. The patient has focal, calcified, or fibrotic stenotic lesions identified on diagnostic angiography and is scheduled for an endovascular transluminal lesion preparation procedure using a bladed, sheathed intravascular device (C1600) prior to definitive angioplasty or stent placement. The clinical workflow: vascular surgery or interventional cardiology evaluates the patient in clinic, reviews noninvasive testing (ABI, duplex ultrasound) and cross-sectional imaging (CTA/MRA), and schedules the patient for an angiography and possible intervention. In the interventional suite under conscious sedation or monitored anesthesia care, arterial access is obtained (commonly common femoral artery), diagnostic angiography is performed to localize the target lesion, and lesion preparation with the bladed, sheathed transluminal device is performed to debulk or modify plaque. Following lesion preparation, adjunctive therapy such as percutaneous transluminal angioplasty (PTA) or stent deployment is performed as indicated. The procedure typically occurs in an ambulatory endovascular suite, hospital catheterization laboratory, or hybrid operating room. Typical monitoring includes vascular access site management and postprocedural hemostasis; recovery time and disposition depend on anesthesia and procedural complexity.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|